We are looking specifically at diagnostics – NICE Guidance – DG34 – tumour profiling for breast cancer, as a recent example. We would like to understand any procurement plans you have in place as a result of this? Including dates, procurement route (open, restricted), regime (whether light touch regime, standard OJEU), likely weightings (quality vs price), or via NHS Supply Chain or other framework provider?

Download response NICE guidelines. 310719